Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes In response to liquidity issues that businesses are facing as a result of the COVID-19 pandemic, The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act” or the “Act”) was signed into law on March 27, 2020 by the U.S. government. The Act provides for a five-year carryback of federal net operating losses generated in tax years beginning in 2018, 2019, or 2020. In addition, the Act temporarily increases the deductible interest expense, for tax years beginning in 2019 and 2020. See further discussion below. The effective tax rate for the three months ended September 30, 2020 (Successor) was 37.2%, reflecting a tax benefit of $9.3 million on a pre-tax loss of $24.9 million, compared to 30.1% for the three months ended September 30, 2019, reflecting a tax benefit of $24.0 million on a pre-tax loss of $79.8 million. The change in the effective tax rate for the three months ended September 30, 2020 as compared to the prior year period was primarily due to favorable adjustments related to the impact of the Act recorded in the current year quarter. The effective tax rate for the nine months ended September 30, 2020 (Successor) was 48.8%, reflecting a tax benefit of $111.1 million on a pre-tax loss of $227.8 million, compared to 20.4% for the period from January 1, 2019 to September 30, 2019 (Successor), reflecting a tax benefit of $84.1 million on a pre-tax loss of $412.9 million, and 26.7% for the period from January 1, 2019 to February 7, 2019 (Predecessor), reflecting a tax benefit of $27.5 million on a pre-tax loss of $102.8 million. The effective tax rate for the nine months ended September 30, 2020 (Successor) was positively impacted by the $57.8 million net benefit resulting from the enactment of the Act which allows for the carryback of U.S. net operating losses arising in 2018, 2019 or 2020 to each of the five preceding years for which the corporate tax rate for certain years was 35% (periods prior to 2018), as compared to the current 21% tax rate. The aforementioned benefit was partially offset by the impact of non-deductible expense associated with the fair value adjustment related to the Series A Preferred Stock make-whole derivative liability. The effective rate for both the period from January 1, 2019 to September 30, 2019 (Successor) and the period from January 1, 2019 to February 7, 2019 (Predecessor), was negatively impacted by non-deductible transaction costs incurred as part of the Take-Private Transaction, partially offset by the excess tax benefit related to the acceleration of the vesting of equity-based awards in connection with the Take-Private Transaction for the period January 1, 2019 to February 7, 2019 (Predecessor).

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.